Metraipolis › archive › dc_1e60cbbb232d

Immunogenicity and safety of a recombinant gE-Fc fusion protein subunit vaccine for herpes zoster in adults ≥50 years of age: a randomised, active-controlled,… — Europe PMC PMID:40817094

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40817094
DOI
10.1038/s41467-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-10T15:00:14.588Z
SHA-256 of the archived text
77e5c7b4e3218b09ada8abf112ffb1b61fabdb2a6ce5617d3f7254cca9d5b015
Stable URL of this page
https://metraipolis.com/documento/dc_1e60cbbb232d

How to cite

Immunogenicity and safety of a recombinant gE-Fc fusion protein subunit vaccine for herpes zoster in adults ≥50 years of age: a randomised, active-controlled,… — Europe PMC PMID:40817094 — Europe PMC (en), https://europepmc.org/article/MED/40817094 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1e60cbbb232d (Metraipolis archive dc_1e60cbbb232d, sha256 77e5c7b4e3218b09ada8abf112ffb1b61fabdb2a6ce5617d3f7254cca9d5b015)
BibTeX
@misc{dc1e60cbbb232d,
  title = {Immunogenicity and safety of a recombinant gE-Fc fusion protein subunit vaccine for herpes zoster in adults ≥50 years of age: a randomised, active-controlled,… — Europe PMC PMID:40817094},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40817094},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1e60cbbb232d; sha256 77e5c7b4e3218b09ada8abf112ffb1b61fabdb2a6ce5617d3f7254cca9d5b015},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40817094. Agents can read the archived copy with the MCP tool read_document.